Latest Publication: Read our teams’ latest paper in Antibiotics, showing reduced nephrotoxicity of a novel formulation of polymyxin B compared to the clinical formulation using a validated primary human proximal tubule cell model.
19th March 2024 - 21 March, 2024
Boston, MA, USA
Hilton Boston Back Bay
Uniting KOLs, industry experts and regulators at the forefront of kidney disease research, the 6th CKD Drug Development Summit is biopharma’s must-attend forum for staying up to date with the latest breakthroughs in surrogate endpoint innovation, novel pathway and target exploration, the advancement of personalized therapies, and much more.
What’s new for 2024:
Share on social media:
Don't miss out on our latest innovations: follow us on Linkedin